Prof. Ehud Cohen, completed his BSc and MSc degrees at the Hebrew University of Jerusalem and joined Prof. Albert Taraboulos’ laboratory where he studied the cell biology and metabolism of the prion protein, focusing on the mechanism that leads to the development of the late onset, familial prion disorder, Gerstmann-Sträussler-Scheinker syndrome (GSS). His research explores the reasons why distinct neurodegenerative maladies onset late in life, a principal mystery in the field of aging research. To explore whether the aging process enables neurodegenerative diseases to onset late in life, he joined Dr. Andrew Dillin's lab (The Salk Institute for Biological Studies, San Diego, California) where he utilized the nematode C. elegans and studied how aging alteration can affect toxicity that stems from the Alzheimer’s disease associated peptide, Aβ. At the beginning of 2009 he returned to Israel to open an independent lab at the Hebrew University Medical School. The lab focuses on the links between the aging process and the genetic, cell biological and biochemical aspects of toxic protein aggregation.